Article info
Heart failure and cardiomyopathies
Original research article
Renin–angiotensin–aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy
- Correspondence to Dr Lian-Yu Lin, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei 100, Taiwan; hspenos{at}gmail.com
Citation
Renin–angiotensin–aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy
Publication history
- Received October 15, 2017
- Revised January 1, 2018
- Accepted January 3, 2018
- First published January 25, 2018.
Online issue publication
January 18, 2021
Article Versions
- Previous version (18 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.